<DOC>
	<DOCNO>NCT01976052</DOCNO>
	<brief_summary>Potential biomarkers obstructive sleep apnea ( OSA ) , full genomic screening evaluate correlated degree OSA effect CPAP-treatment measure polygraphy .</brief_summary>
	<brief_title>Evaluation Potential Biomarkers Obstructive Sleep Apnea Effect Positive Pressure Treatment</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>OSApatients moderate severe OSA ( n=15+15 ) 1 . Adult , 1875 year age 2 . Moderate ( AHI 1530 ) Severe ( AHI &gt; 30 ) OSA currently untreated plan CPAPtreatment 3 . Otherwise healthy except well control hypertension since 3 month , Max BP 140/90 4 . Nonsmokers 5 . Not pregnant 6 . No medication antioxidants 7 . BMI &lt; 40 Controls ( AHI &lt; 5 ) Two group control 1 . Matched control The age , sex BMI Â± 3 eventual hypertension . These control also fulfill criterion 46 . 2 . Healthy control normal BMI ( 1925 ) These control also fulfill criterion 1. , 46 . If fulfil inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Genomics</keyword>
</DOC>